Skip to content

Oral Tolerance in Cow's Milk Allergy in the Infant

Oral Tolerance in Cow's Milk Allergy in the Infant: Role of CD4+CD25+ T Cells and Intestinal Microflora

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00298376
Enrollment
50
Registered
2006-03-02
Start date
2006-03-31
Completion date
Unknown
Last updated
2007-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cow's Milk Allergy

Keywords

Cow's milk allergy,, food allergy, oral tolerance,, infant,, regulatory T cells,, intestinal microflora

Brief summary

This study aims to determine if there is a link between cow's milk allergy in infants and regulatory T cells dysfunction that should be transient in infant acquiring oral tolerance after 12 month avoiding food and persistent in others. Cow's milk allergy is evaluated by basophils activation test, T cells activation test, specific humoral response (IgA, IgE, IgG) in allergic infants before and after 12 month avoiding food, before and after low dose milk exposure, before and after oral challenge. Number and function of regulatory T cells and microflora composition are measured at the same time. Allergic infants are compared to age matched control group.

Interventions

None listed

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to 15 Months
Healthy volunteers
Yes

Inclusion criteria

male or female, age before 6 month, cow's milk allergy with positive prick or patch test for cow's milk Control group: male or female, age before 6 month or within 12 and 18 month, eating cow's milk every day

Exclusion criteria

immunodeficiency syndrome, lactose intolerance Control group: other food allergy, atopic dermatitis.

Countries

France

Contacts

Primary ContactFlorence VILLARD-TRUC, MD
fvillardtruc@hotmail.com33 472 110 390
Backup ContactDominique KAISERLIAN, PhD
kaiserlian@cervi-lyon.inserm.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026